| Study summary: |
|
Arayvan Clinical Research of Arlington, TX is recruiting for future Type 2 Diabetes Mellitus study, where participant's have been newly diagnosed (less than 12 months), at least 18 years of age, and who have not taken any antidiabetic therapy 12 weeks prior to their randomization. Potentially qualifying patients will be newly diagnosed and uncontrolled Type 2 Diabetes patients with glycated (or glycosylated) haemoglobin (HbA1c) levels of 8.5% to 12.0%.
In this study, participants will be given a FDA approved investigational medication to take by mouth, free of charge. To participate, you will need to be seen in our office for 9 visits, over a 24 week period. During these visits, participants will complete several events, such as questionnaires, medical history forms, physical, diet consultation, etc. Some visits can be scheduled during the evenings, weekends, holidays, as well as during our normal business hours. |
| Participants may receive: |
|
Financial compensation up to $600 for time and travel. Participants are not compensated for unscheduled visits or pre-screening visits. Once you speak with a member of our staff, you will find out more details about the study and further assessment can be made to determine you eligibility. |